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Abstract – Various nucleophiles, such as indole, 1,2,3-trimethoxybenzene, 
anisole, phenol, and pyrrole, reacted with 1-hydroxy-Nb-trifluoroacetyltryptamine 
under the presence of mesyl chloride to give novel series of (3a,8a- 
cis)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indoles having a substituent at the 3a- 
position. Their structures and by-products were strictly determined.
INTRODUCTION     
We have opened the door to the chemistry of 1-hydroxyindole and 1-hydroxytryptophan derivatives,3 and 
demonstrated that these compounds generally undergo nucleophilic substitution reaction,4 which was thus 
far rarely observed in indole chemistry.4  
In our 1-hydroxyindole hypothesis,5 we assume the 1-hydroxy group of the general formula (A) in 
Scheme 1 departs, after being transformed to a good leaving group (B), leaving a resonance stabilized 
indolyl cation6 (C). It would be possible to trap it with suitable nucleophiles to give imine6 (D).  
  




























 Subsequent cyclization of Nb-nitrogen on the side chain results in providing simple and novel 
methodology for the preparation of (3a,8a-cis)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indoles (E) having 
an employed nucleophile at the 3a-position. According to the idea, we first employed indole as a 
nucleophile and reported the result as the previous communication.7 This is its full report together with 
the results of additionally examined nucleophiles such as 1,2,3-trimethoxybenzene, anisole, phenol, and 
pyrrole.  
 
RESULTS AND DISCUSSION 
I. Reaction of 1-hydroxy-Nb-trifluoroacetyltryptamine (2) with indole   
Nb-Trifluoroacetyltryptamine (1, Scheme 2) was converted to 1-hydroxy-Nb-trifluoroacetyltryptamine (2) 
by our 1-hydroxyindole synthetic method.3 Then, 2 was reacted with mesyl chloride (MsCl) in 
1,2-dichloroethane in the presence of indole (3 mol eq) and trimethylamine (Et3N) at 0 °C (Table 1, Entry 
3). As expected, smooth reaction occurred to provide 1,2,3,8-tetrahydro-1-trifluoroacetylpyrrolo[2,3-b]- 
indole8,9 (3),  (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-3a-(indol-2-yl)- (4), -3a-(indol-3-yl)-1-trifluoro- 
acetylpyrrolo[2,3-b]indole (5), and 6-mesyloxy-Nb-trifluoroacetyltryptamine8,9 (6), in 13, 5, 11, and 3% 
yields, respectively.  
With an attempt to improve the product yield of nucleophilic reaction and examine solvent effect, 
1,2-dichloroethane was changed to benzene, CHCl3, THF, DMF, MeCN, MeNHCHO, and EtOAc. The 
product and their distribution ratio variably changed and their results are summarized in Table 1.  
When the reaction was carried out in CHCl3 (Entry 2), the yield of 5 was improved to 21% together with 
the formations of 3, 4, and 6 in the respective yields of 14, 5, and 4%. Under similar reaction conditions, 
the use of excess indole (10 mol eq., Entry 8) further raised the yield of 5 up to 30% in addition to the 
concomitant formations of 3, 4, and 6 in 4, 7, and 1% yields, respectively.  
In the case of THF as the solvent, various products were formed (Entry 4). Thus, the reaction of 2 with 
MsCl in THF in the presence of indole (3 mol eq) and Et3N at 0 °C gave 3, 4, 5, 6, 3H-3-(indol-3-yl)- 
Nb-trifluoroacetyltryptamine (7), and (3a,8a-cis)-3a-(4-chlorobutoxy)-1,2,3,3a,8,8a-hexahydro-1-tri- 
fluoroacetylpyrrolo[2,3-b]indole9 (8), in 28, 6, 15, 5, 4, and 6% yields, respectively. From the results 

































 MeNHCHO produced (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-3a-hydroxy-1-trifluoroacetylpyrrolo[2,3-b]in- 
dole (9) as a major product (Entry 7).  
 
II. Reaction of 1-hydroxy-Nb-trifluoroacetyltryptamine (2) with nucleophiles 
We next examined aromatic electron rich nucleophiles. When 1,2,3-trimethoxybenzene (10 mol eq.) was 
employed in the reaction of 2 with MsCl in CHCl3 in the presence of Et3N (Scheme 3), (3a,8a- 
cis)-1,2,3,3a,8,8a-hexahydro-1-trifluoroacetyl-3a-(2,3,4-trimethoxyphenyl)pyrrolo[2,3-b]indole (10), 3, 6, 
1, and (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-1-trifluoroacetyl-3a-[3-(Nb-trifluoroacetyl)aminoethylindol-1- 
yl]pyrrolo[2,3-b]indole (11a) were formed in 2, 15, 4, 4, and 13% yields, respectively. Further treatment 
of 11a with NaHCO3 afforded 11b in 67% yield.    
Under similar reaction conditions with anisole as a nucleophile,  (3a,8a-cis)-1,2,3,3a,8,8a-hexa- 
hydro-3a-(4-methoxyphenyl)-1-trifluoroacetylpyrrolo[2,3-b]indole (12), 3, 1, and 11a were isolated in the 
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Table 1. Solvent effect on the product formation and distribution
*
* 1 was obtained in 6% yield.Entries 8—10
 respective yields of 5, 18, 6, and 10%. 12 was easily converted to  (3a,8a-cis)-1,2,3,3a,8,8a-hexa- 
hydro-3a-(4-methoxyphenyl) pyrrolo[2,3-b]indole (13) in 94% yield by the treatment with aq. NaHCO3. 
In the case of employing phenol as a nucleophile, (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-3a- 
(4-hydroxyphenyl)- (14) and -3a-(2-hydroxyphenyl)-1-trifluoroacetylpyrrolo[2,3-b]indole (15) were 
produced in addition to 6, 1, and 11a in 3, 5, 4, 8, and 8% yields, respectively. The compound 14 was 
derived to 12 in 73% yield by the reaction with CH2N2.  
 
Since pyrrole is a good nucleophile, expected product, (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-3a- 
(pyrrol-2-yl)-1-trifluoroacetylpyrrolo[2,3-b]indole (16), was obtained in rather better yield (29%) 
compared to the above products (10–12, 14, 15) together with 3, 1, and 11a in 6, 7, and 8% yields, 
respectively. Formation of the other expected isomer, pyrrol-3-yl isomer (17), was not detected at all. 
Treatment of 16 with Ac2O-pyridine afforded (3a,8a-cis)-8-acetyl-1,2,3,3a,8,8a-hexahydro-3a-(pyrrol-2- 
yl)-1-trifluoroacetylpyrrolo[2,3-b]indole (18) in 83% yield.   



























































































a) R = COCF3







MsCl (1.3 mol eq.), 
Et3N, CHCl3
MsCl (5 mol eq.), 
Et3N, CHCl3





 Structures of various products reported in the above sections were determined spectroscopically. In cases 
where spectroscopically more than two structures were possible candidates, the product was led to 
suitable derivative which could prove its structure. 
The high resolution MS and other spectral data of 4 and 5 show the presence of an extra indole moiety in 
both molecules. In the 1H-NMR spectra, 4 and 5 show characteristic C-(8a) proton signal at δ5.63 and 
5.92, respectively, proving the presence of hexahydropyrrolo[2,3-b]indole skeleton. In addition, 5 has a 
long-range coupled doublet proton (J=2.5 Hz) at δ6.93 and is assigned to be C(2')-proton, which is 
unusually shielded compared to the usual indole C(2)-proton.10,11 In the spectrum of 4, a double doublets 
proton (J=2.2 and 0.7 Hz) resonates at δ6.48, which is attributed to the C(3')-proton. The structures of 4 
and 5 were further confirmed by treating them with Ac2O and pyridine to provide the acetyl derivatives 
(20 and 19) in the respective yields of 97 and 51% (Scheme 4). From these data, 4 and 5 were deduced to 
be indol-2-yl and indol-3-yl isomers, respectively. 
Repeated recrystallization of 4 formed suitable prisms for X-ray single crystallographic analysis and the 
structure was determined unequivocally as shown in Figure 1. Since the indol-2-yl structure of 4 is 
established, then it determines that the other isomer (5) is the indol-3-yl isomer. The preferred formation 











































































































 The structure of 6 was proved as reported in the previous paper9 by converting it to 1-acetyl- 
6-mesyloxy-Nb-trifluoroacetyltryptamine (21) in 25% yield by the treatment with NaH-AcCl. The 
compound (7) has a ring opened structure of 5. It was proved by isolating 7 in 89% yield when 5 was 
heated in DMSO at 130 °C.  
To establish the structure of 9, it was converted to the common compound for structural determination by 
series of reactions. First, 9 was led to (3a,8a-cis)-3a-acetoxy- (22) and -8-acetyl-1,2,3,3a,8,8a- 
hexahydro-1-trifluoroacetylpyrrolo[2,3-b]indole (23) in 71 and 17% yields, respectively, by the reaction 
with Ac2O-pyridine at rt. Treatment of 22 with Ac2O-pyridine at 55 °C afforded 23 in 62% yield together 
with 26% yield of recovery. Hydrolysis of trifluoroacetyl group of 23 with aq. NaHCO3 at rt provided 
(3a,8a-cis)-3a-acetoxy-8-acety-1,2,3,3a,8,8a-hexahydro- (24) and (3a,8a-cis)-8-acety-1,2,3,3a,8,8a-hexa- 
hydro-3a-hydroxypyrrolo[2,3-b]indole (25) in 80 and 19% yields, respectively. At the reflux conditions 
23 gave 98% yield of 25. Treatment of both 24 and 25 with Ac2O-pyridine at rt furnished (3a,8a- 
cis)-3a-acetoxy-1,8-diacetyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (26) in the respective yields of 
99 and 96%.  
On the other hand, 26 was obtained from 273,4 by the treatment with Ac2O-NaOAc. Aside from this, 26 
was produced by the treatment with Ac2O-pyridine in 80% yield from (3a,8a-cis)-1-acetyl-1,2,3,3a,8,8a- 
hexahydro-3a-hydroxypyrrolo[2,3-b]indole (29), which was derived in 80% yield from  8b-(2-acetyl- 
aminoethyl)-2,2-dimethyl-4H-1,3-dioxolo[4,5-b]indole (28) by the treatment with K2CO3. Since the 
structure of a derivative of 28 is determined by X-ray single crystallographic analysis as reported in our 
previous paper,12 the structure of common compound (26) is established. 
In conclusion, 1-hydroxy-Nb-trifluoroacetyltryptamine is a suitable starting material for obtaining novel 
type of (3a,8a-cis)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indoles carrying aromatic and/or heteroaromatic 
substituent at the 3a position. Among this family members are core structures of Leptosins A–F,13 which 
are cytotoxic substances against P-388 lymphocytic leukemia cell line comparable to that of mytomycin 
C. Therefore, we expect that compounds shown in this paper would have a useful biological activity.  
 
Experimental 
Melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected. 
Infrared (IR) spectra with a Shimadzu IR-420, a Shimadzu IR-460, and a Horiba FT-720 
spectrophotometer and proton nuclear magnetic resonance (1H-NMR) spectra with a JEOL JNM-GSX 
500 spectrometer with tetramethylsilane as an internal standard. Mass spectra (MS) were recorded on a 
JEOL SX-102A spectrometer. Column chromatography was performed on silica gel (SiO2, 100-200 mesh, 
from Kanto Chemical Co. Inc.) throughout the present study. The solution of diazomethane (CH2N2) in 
diethylether (Et2O) was prepared as follows: a solution of potassium hydroxide (KOH) (5.50 g, 98.0 
 mmol) in H2O (8.0 mL) was placed in a 500 mL round bottom flask and cooled in an ice bath. The 95% 
EtOH (25 mL), Et2O (60.0 mL), and p-tolylsulfonylmethylnitrosoamide (21.5 g, 100 mmol) were added 
and the whole was slowly distilled to give the Et2O solution including about 3 g of CH2N2. Anhydrous 
N,N-dimethylformamide (DMF), tetrahydrofuran (THF), and CHCl3 were prepared by distillation over 
calcium hydride, sodium, and calcium chloride, respectively. 
Reaction of 1-hydroxy-Nb-trifluoroacetyltryptamine (2) with indole as a nucleophile: 
1,2,3,8-Tetrahydro-1-trifluoroacetylpyrrolo[2,3-b]indole (3), (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro- 
3a-(indol-2-yl)-1-trifluoroacetyl- (4), -3a-(indol-3-yl)-1-trifluoroacetyl- (5), (3a,8a-cis)-3a-(4-chloro- 
butoxy)-1,2,3,3a,8,8a-hexahydro-1-trifluoroacetylpyrrolo[2,3-b]indole (8), 6-mesyloxy-Nb-trifluo- 
roacetyltryptamin (6), 3H-3-(indol-3-yl)-Nb-trifluoroacetyltryptamine (7) from 2 — [Table 1, Entry 
4]: A solution of MsCl (232.9 mg, 1.99 mmol) in anhydrous THF (2.0 mL) was added to a solution of 2 
(419.9 mg, 1.54 mmol) and indole (542.6 mg, 4.73 mmol) in anhydrous THF (14.0 mL) and Et3N (1.6 mL, 
11.5 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After addition of H2O under ice cooling, 
the whole was extracted with CHCl3–MeOH (95:5, v/v). The extract was washed with brine, dried over 
Na2SO4, and evaporated under reduced pressure to leave an oil, which was column-chromatographed on 
SiO2 successively with CHCl3–hexane (1:1, v/v), CHCl3, CHCl3–MeOH (95:5, v/v), EtOAc–hexane (1:5, 
v/v), and EtOAc–hexane (1:2, v/v) to give 3 (107.7 mg, 28%), 8 (31.9 mg, 6%), 4 (31.4 mg, 6%), 5 (86.3 
mg, 15%), 7 (23.4 mg, 4%), and 6 (29.4 mg, 5%) in the order of elution. 3: mp 238.0—240.0 °C 
(decomp., colorless plates, recrystallized from CH2Cl2–hexane). IR (KBr): 3370, 1670, 1446, 1351, 1278, 
1233, 1203, 1139, 1069, 746 cm-1. 1H-NMR (CDCl3) δ: 3.30 (2H, t, J=7.4 Hz), 4.71 (2H, t, J=7.4 Hz), 
7.15 (1H, dt, J=1.6, 6.9 Hz), 7.18 (1H, dt, J=1.6, 6.9 Hz), 7.36 (1H, dd, J=1.6, 6.9 Hz), 7.42 (1H, dd, 
J=1.6, 6.9 Hz), 9.11 (1H, br s). High resolution MS m/z: Calcd for C12H9F3N2O: 254.0666. Found: 
254.0662. 4: mp 223.0—225.0 °C (decomp., colorless prisms, recrystallized from CHCl3). IR (KBr): 
3365, 1676, 1605, 1482, 1465, 1453, 1205, 1183, 1179, 745 cm-1. 1H-NMR (CDCl3) δ: 2.60 (1/11H, dd, 
J=12.5, 5.6 Hz), 2.76 (10/11H, dd, J=12.5, 5.6 Hz), 2.81 (1/11H, td, J=12.5, 7.8 Hz), 2.93 (10/11H, td, 
J=12.5, 7.8 Hz), 3.34 (1/11H, td, J=12.5, 5.6 Hz), 3.45 (10/11H, td, J=12.5, 5.6 Hz), 4.10 (10/11H, m), 
4.32 (1/11H, m), 4.54 (1/11H, s, disappeared on addition of D2O), 5.30 (10/11H, s, disappeared on 
addition of D2O), 5.63 (10/11H, s), 5.75 (1/11H, s), 6.48 (10/11H, dd, J=2.2, 0.7 Hz), 6.50 (1/11H, dd, 
J=2.2, 0.7 Hz), 6.76 (1/11H, d, J=7.6 Hz), 6.78 (10/11H, d, J=7.6 Hz), 6.83 (10/11H, dt, J=7.6, 1.0 Hz), 
6.86 (1/11H, dt, J=7.6, 1.0 Hz), 7.07 (10/11H, dt, J=7.6, 1.0 Hz), 7.10 (10/11H, br d, J=7.6 Hz), 7.13 
(10/11H, td, J=7.6, 1.0 Hz), 7.19 (10/11H, td, J=7.6, 1.0 Hz), 7.22 (10/11H, dd, J=7.6, 1.0 Hz), 
7.07—7.24 (5/11H, m), 7.56 (10/11H, dd, J=7.6, 0.7 Hz), 7.58 (1/11H, dd, J=7.6, 0.7 Hz), 7.77 (1/11H, 
br s), 7.94 (10/11H, br s). High-resolution MS m/z: Calcd for C20H16F3N3O: 371.1246. Found: 371.1244. 
 5: colorless oil. IR (film): 3405, 1681, 1467, 1460, 1204, 1185, 1145, 744 cm-1. 1H-NMR (CDCl3) δ: 
2.47—2.53 (1/6H, m), 2.64—2.70 (5/6H, m), 2.87—2.96 (1/6H, m), 3.02—3.11 (5/6H, m), 3.32—3.40 
(1/6H, m), 3.45—3.52 (5/6H, m), 4.19 (5/6H, m), 4.30—4.36 (1/6H, m), 4.71 (1/6H, br s, disappeared on 
addition of D2O), 5.25 (5/6H,br s, disappeared on addition of D2O), 5.92 (5/6H, s), 6.00 (1/6H, br s), 6.90 
(5/6H, d, J=2.5 Hz), 6.93 (1/6H, d, J=2.5 Hz), 7.06—7.12 (1/6H, m), 7.09 (5/6H, ddd, J=8.1, 7.1, 1.0 Hz), 
7.12—7.26 (8/6H, m), 7.16 (5/6H, td, J=7.6, 1.2 Hz), 7.22 (5/6H, d, J=7.6 Hz), 7.36 (5/6H, d, J=8.1 Hz), 
7.38 (1/6H, d, J=8.1 Hz), 7.39 (1/6H, d, J=8.1 Hz), 7.54 (5/6H, d, J=8.1 Hz), 8.02 (5/6H, br s), 8.05 (1/6H, 
br s). High-resolution MS m/z: Calcd for C20H16F3N3O: 371.1245. Found: 371.1246. 6: mp 114.5— 
115.5 °C (colorless needles, recrystallized from CH2Cl2–hexane). IR (KBr): 3430, 3340, 1700, 1563, 
1349, 1206, 1172, 1119, 976, 952, 870 cm-1. 1H-NMR (CDCl3) δ: 3.04 (2H, t, J=6.6 Hz), 3.15 (3H, s), 
3.67 (2H, q, J=6.6 Hz), 6.37 (1H, br s), 7.05 (1H, d, J=8.8 Hz), 7.11 (1H, s), 7.37 (1H, s), 7.58 (1H, d, 
J=8.8 Hz), 8.26 (1H, br s). High resolution MS m/z: Calcd for C13H13F3N2O4S: 350.0547. Found: 
350.0539. 7: very pale yellow oil. IR (film): 3402, 1709, 1213, 1180, 1167, 746 cm-1. 1H-NMR 
(DMSO-d6) δ: 3.00 (2H, tm, J=8.1 Hz), 3.39—3.41 (2H, m), 7.02 (1H, ddd, J=8.0, 7.0, 1.1 Hz), 7.07 (1H, 
ddd, J=8.0, 7.0, 1.1 Hz), 7.11 (1H, ddd, J=8.0, 7.0, 1.1 Hz), 7.19 (1H, ddd, J=8.0, 7.0, 1.1 Hz), 7.38 (1H, 
d, J=8.0 Hz), 7.48 (1H, d, J=8.0 Hz), 7.55 (1H, d, J=8.0 Hz), 7.64 (1H, d, J=2.4 Hz), 7.72 (1H, d, J=8.0 
Hz), 9.62 (1H, br t, J=5.6 Hz disappeared on addition of D2O), 11.0 (1H, s), 11.5 (1H, br s, disappeared 
on addition of D2O). High-resolution MS m/z: Calcd for C20H16F3N3O: 371.1245. Found: 371.1248. 8: 
colorless oil. IR (film): 3370, 2940, 1694, 1612, 1486, 1471, 1255, 1206, 1145, 1101, 1066, 750 cm-1. 
1H-NMR (CDCl3) δ: 1.60—1.69 (2H, m), 1.75—1.83 (2H, m), 2.34—2.41 (2/6H, m), 2.47—2.59 (10/6H, 
m), 3.15 (1H, dt, J=8.8, 6.4 Hz), 3.30 (1H, dt, J=8.8, 6.4 Hz), 3.36 (1H, dt, J=6,4, 11.2 Hz), 3.49 (2H, t, 
J=7.8 Hz), 3.95—3.98 (5/6H, m), 4.14—4.18 (1/6H, m), 5.52 (5/6H, s), 5.64 (1/6H, d, J=2.0 Hz), 6.65 
(1H, d, J=7.8 Hz), 6.85 (1H, t, J=7.8 Hz), 7.22 (1H, t, J=7.8 Hz), 7.23 (1H, d, J=7.8 Hz). High resolution 
MS m/z: Calcd for C16H18ClF3N2O2: 364.0978 and 362.1008. Found: 364.1003 and 362.1022. 
[Entry 1] A solution of MsCl (67.0 mg, 0.59 mmol) in benzene (1.0 mL) was added to a solution of 2 
(119.0 mg, 0.44 mmol) and indole (155.0 mg, 1.32 mmol) in benzene (3.0 mL) and Et3N (0.4 mL, 2.87 
mmol) at 0 °C and the mixture was stirred at 0°C for 1 h. After the same work-up and separation as 
described in Entry 4, 3 (19.9 mg, 18%), 5 (6.7 mg, 4%), and 7 (6.7 mg, 4%) were obtained in the order of 
elution. 
[Entry 2] A solution of MsCl (73.4 mg, 0.64 mmol) in anhydrous CHCl3 (1.0 mL) was added to a 
solution of 2 (113.5 mg, 0.42 mmol) and indole (146.1 mg, 1.25 mmol) in anhydrous CHCl3 (3.0 mL) and 
Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0°C for 1 h. After the same work-up and 
separation as described in Entry 4, 3 (15.2 mg, 14%), 4 (7.1 mg, 5%), 5 (33.1 mg, 21%), and 6 (5.7 mg, 
 4%) were obtained in the order of elution. 
[Entry 3] A solution of MsCl (60.3 mg, 0.53 mmol) in anhydrous ClCH2CH2Cl (1.0 mL) was added to a 
solution of 2 (111.6 mg, 0.41 mmol) and indole (143.7 mg, 1.23 mmol) in anhydrous ClCH2CH2Cl (3.0 
mL) and Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same 
work-up and separation as described in Entry 4, 3 (13.8 mg, 13%), 4 (7.6 mg, 5%), 5 (16.4 mg, 11%), and 
6 (3.8 mg, 3%) were obtained in the order of elution. 
[Entry 5] A solution of MsCl (59.4 mg, 0.52 mmol) in anhydrous DMF (1.0 mL) was added to a solution 
of 2 (101.0 mg, 0.37 mmol) and indole (131.9 mg, 1.13 mmol) in anhydrous DMF (3.0 mL) and Et3N (0.4 
mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same work-up and 
separation as described in Entry 4, 3 (28.2 mg, 30%), 4 (1.6 mg, 1%), 5 (9.8 mg, 7%), and 6 (1.9 mg, 2%) 
were obtained in the order of elution. 
[Entry 6] A solution of MsCl (59.2 mg, 0.52 mmol) in MeCN (1.0 mL) was added to a solution of 2 
(107.8 mg, 0.39 mmol) and indole (137.8 mg, 1.18 mmol) in MeCN (3.0 mL) and Et3N (0.4 mL, 2.87 
mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same work-up and separation as 
described in Entry 4, 3 (10.0 mg, 10%), 4 (1.5 mg, 1%), 5 (12.2 mg, 8%), and 1 (5.8 mg, 6%) were 
obtained in the order of elution. 
[Entry 7] A solution of MsCl (57.5 mg, 0.50 mmol) in anhydrous MeNHCHO (1.0 mL) was added to a 
solution of 2 (108.2 mg, 0.39 mmol) and indole (140.5 mg, 1.20 mmol) in anhydrous MeNHCHO (3.0 
mL) and Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same 
work-up and separation as described in Entry 4, 3 (1.7 mg, 2%), 4 (1.1 mg, 1%), 5 (4.4 mg, 4%), 
(3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-3a-hydroxy-1-trifluoroacetylpyrrolo[2,3-b]indole (9) (21.2 mg, 20%), 
and unreacted 2 (22.0 mg, 20%) were obtained in the order of elution. 9: mp 115.0—115.5 °C (colorless 
prisms, recrystallized from CHCl3–hexane). IR (KBr): 3336, 3282, 1697, 1685, 1469, 1250, 1201, 1147, 
750 cm-1. 1H-NMR (DMSO-d6, 120°C) δ: 2.14—2.53 (2H, m), 3.22—3.43 (1H, m), 3.84—4.03 (1H, m), 
5.36 (1H, br s), 5.56 (1H, br s), 6.26 (1H, br s), 6.60 (1H, d, J=7.6 Hz), 6.69 (1H, br t, J=7.6 Hz), 7.06 
(1H, t, J=7.6 Hz), 7.21 (1H, d, J=7.6 Hz). High-resolution MS m/z: Calcd for C12H11F3N2O2: 272.0773. 
Found: 272.0772.    
[Entry 8] A solution of MsCl (63.3 mg, 0.55 mmol) in anhydrous CHCl3 (1.0 mL) was added to a 
solution of 2 (111.7 mg, 0.41 mmol) and indole (481.0 mg, 4.11 mmol) in anhydrous CHCl3 (3.0 mL) and 
Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same work-up and 
separation as described in Entry 4, 3 (4.4 mg, 4%), 4 (10.3 mg, 7%), 5 (46.1 mg, 30%), and 6 (1.9 mg, 
1%) were obtained in the order of elution.  
[Entry 9] A solution of MsCl (57.4 mg, 0.50 mmol) in anhydrous ClCH2CH2Cl (1.0 mL) was added to a 
solution of 2 (103.8 mg, 0.38 mmol) and indole (444.7 mg, 3.80 mmol) in anhydrous ClCH2CH2Cl (3.0 
 mL) and Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same 
work-up and separation as described in Entry 4, 3 (7.4 mg, 8%), 4 (7.3 mg, 5%), 5 (25.5 mg, 18%), and 6 
(2.3 mg, 2%) were obtained in the order of elution. 
[Entry 10] A solution of MsCl (59.3 mg, 0.52 mmol) in anhydrous EtOAc (1.0 mL) was added to a 
solution of 2 (111.7 mg, 0.41 mmol) and indole (479.8 mg, 4.10 mmol) in anhydrous EtOAc (3.0 mL) 
and Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After the same work-up 
and separation as described in Entry 4, 3 (6.4 mg, 6%), 4 (11.1 mg, 7%), 5 (38.6 mg, 25%), and 6 (4.9 mg, 
3%) were obtained in the order of elution.   
7 from 5 — A solution of 5 (10.0 mg, 0.03 mmol) in DMSO (2.0 mL) was stirred at 130 °C for 3 h. After 
addition of H2O and EtOAc, the organic layer was washed with H2O and brine, dried over Na2SO4, and 
evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO2 with 
EtOAc–hexane (1:5, v/v) to give 7 (8.9 mg, 89%). 
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-1-trifluoroacetyl-3a-(2,3,4-trimethoxyphenyl)pyrrolo[2,3-b]in- 
dole (10), and (3a,8a-cis)-1,2,3,3a,8,8a-hexahydro-1-trifluoroacetyl-3a-[3-(Nb-trifluoroacetyl)- 
aminoethylindol-1-yl]pyrrolo[2,3-b]indole (11a) from 2 — A solution of MsCl (55.1 mg, 0.48 mmol) 
in anhydrous CHCl3 (1.0 mL) was added to a solution of 2 (100.1 mg, 0.37 mmol) and 1,2,3-tri- 
methoxybenzene (619.0 mg, 3.69 mmol) in anhydrous CHCl3 (3.0 mL) and Et3N (0.4 mL, 2.87 mmol) at 
0 °C and the mixture was stirred at 0 °C for 1 h. After addition of H2O under ice cooling, the whole was 
extracted with CHCl3–MeOH (95:5, v/v). The extract was washed with brine, dried over Na2SO4, and 
evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO2 
successively with CHCl3–hexane (1:1, v/v), CHCl3–MeOH (98:2, v/v), and EtOAc–hexane (1:5,v/v) to 
give 3 (14.2 mg, 15%), 10 (2.4 mg, 2%), 11a (11.8 mg, 13%), 1 (4.0 mg, 4%), and 6 (5.4 mg, 4%) in the 
order of elution. 10: colorless oil. IR (film): 1684, 1466, 1203, 1144, 1103, 752 cm-1. 1H-NMR 
(DMSO-d6, 120°C) δ: 2.36—2.58 (1H, m), 2.71—2.92 (1H, m), 3.19—3.34 (1H, m), 3.65 (3H, br s), 3.74 
(3H, s), 3.77 (3H, s), 3.90—4.10 (1H, m), 5.86 (1H, br s), 6.37 (1H, br s), 6.61—6.70 (2H, m), 6.66 (1H, 
d, J=8.8 Hz), 6.87 (1H, d, J=8.8 Hz), 7.01 (1H, t, J=7.3 Hz), 6.99—7.10 (1H, m). High-resolution MS 
m/z: Calcd for C21H21F3N2O4: 422.1453. Found: 422.1448. 11a: colorless oil. IR (film): 1689, 1209, 1186, 
1153, 752 cm-1. 1H-NMR (DMSO-d6, 120 °C) δ: 2.58—3.03 (4H, m), 3.27—3.47 (1H, m), 3.42 (2H, q, 
J=6.6 Hz), 4.02—4.12 (1H, m), 5.87 (1H, br s), 6.64—6.75 (3H, m), 7.00—7.07 (2H, m), 7.11 (1H, t, 
J=8.2 Hz), 7.16 (1H, t, J=8.2 Hz), 7.21 (1H, d, J=8.2 Hz), 7.26 (1H, d, J=8.2 Hz), 7.49 (1H, d, J=8.2 Hz), 
8.96 (1H, br s). High-resolution MS m/z: Calcd for C24H20F6N4O2: 510.1490. Found: 510.1486. 
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-3a-[3-(Nb-trifluoroacetyl)aminoethylindol-1-yl]pyrrolo[2,3-b]- 
indole (11b) from (11a) — Sat. aq. NaHCO3 (2.0 mL, 2.1 mmol) was added to a solution of 11a (25.3 
mg, 0.05 mmol) in MeOH (4.0 mL) and the mixture was stirred at rt for 3 h. After addition of H2O, the 
 whole was extracted with CHCl3. The extract was washed with brine, dried over Na2SO4, and evaporated 
under reduced pressure to leave an oil. Then H2O layer was evaporated under reduced pressure to leave 
an oil. These oils were combined and column-chromatographed on SiO2 with CHCl3–MeOH (97:3, v/v) 
to give 11b (13.8 mg, 67%). 11b: colorless oil. IR (film): 1709, 1213, 1182, 1161, 746 cm-1. 1H-NMR 
(CDCl3) δ: 2.36—2.42 (1H, m), 2.61—2.70 (1H, m), 2.85 (2H, t, J=6.6 Hz), 2.94—3.02 (1H, m), 
3.22—3.30 (1H, m), 3.48—3.60 (2H, m), 4.20 (1H, br s, disappeared on addition of D2O), 5.31 (1H, s), 
6.26 (1H, br s), 6.59 (1H, d, J=7.7 Hz), 6.64 (1H, s), 6.83 (1H, t, J=7.7 Hz), 7.11 (1H, t, J=7.7 Hz), 7.19 
(1H, t, J=7.7 Hz), 7.24 (1H, t, J=7.7 Hz), 7.33 (1H, d, J=7.7 Hz), 7.38 (1H, d, J=7.7 Hz), 7.46 (1H, d, 
J=7.7 Hz). High-resolution MS m/z: Calcd for C22H21F3N4O: 414.1668. Found: 414.1647. 
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-3a-(4-methoxyphenyl)-1-trifluoroacetylpyrrolo[2,3-b]indole 
(12) from 2 — A solution of MsCl (56.8 mg, 0.49 mmol) in anhydrous CHCl3 (1.0 mL) was added to a 
solution of 2 (99.4 mg, 0.37 mmol) and anisole (2 mL, 18.4 mmol) in anhydrous CHCl3 (1.0 mL) and 
Et3N (0.4 mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After addition of H2O under 
ice cooling, the whole was extracted with CHCl3–MeOH (95:5, v/v). The extract was washed with brine, 
dried over Na2SO4, and evaporated under reduced pressure to leave an oil, which was 
column-chromatographed on SiO2 with EtOAc–hexane (1:7, v/v) to give 3 (16.5 mg, 18%), 12 (6.0 mg, 
5%), 11a (9.6 mg, 10%), and 1 (6.0 mg, 6%) in the order of elution. 12: colorless oil. IR (film): 1684, 
1252, 1186, 1144 cm-1. 1H-NMR (CDCl3) δ: 2.52—2.58 (1/11H, m), 2.61—2.67 (1/11H, m), 2.67—2.80 
(20/11H, m), 3.22—3.31 (1/11H, m), 3.38 (10/11H, td, J=11.3, 6.2 Hz), 3.79 (30/11H, s), 3.88 (3/11H, s), 
4.01—4.09 (10/11H, m), 4.24—4.30 (1/11H, m), 4.65 (1/11H, br s, disappeared on addition of D2O), 5.22 
(10/11H, br s, disappeared on addition of D2O), 5.65 (10/11H, s), 5.71 (1/11H, br s), 6.68 (1H, d, J=7.5 
Hz), 6.79 (10/11H, td, J=7.5, 0.8 Hz), 6.77—6.87 (1/11H, m), 6.83 (20/11H, dm, J=8.9 Hz), 6.85 (2/11H, 
dm, J=8.9 Hz), 7.01 (1/11H, d, J=7.5 Hz), 7.06 (10/11H, d, J=7.5 Hz), 7.12 (10/11H, td, J=7.5, 1.3 Hz), 
7.10—7.15 (1/11H, m), 7.20 (2/11H, dm, J=8.9 Hz), 7.26 (20/11H, dm, J=8.9 Hz). High-resolution MS 
m/z: Calcd for C19H17F3N2O2: 362.1242. Found: 362.1244.    
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-3a-(4-methoxyphenyl)pyrrolo[2,3-b]indole (13) from 12 — Sat. 
aq. NaHCO3 (0.5 mL, 0.53 mmol) was added to a solution of 12 (6.2 mg, 0.02 mmol) in MeOH (1.0 mL) 
and the mixture was refluxed for 40 min with stirring. The solvent was evaporated under reduced pressure 
to leave a solid, which was column-chromatographed on SiO2 with CHCl3–MeOH (95:5, v/v) to give 13 
(4.3 mg, 94%). 13: pale yellow oil. IR (film): 2929, 1606, 1512, 1250, 746 cm-1. 1H-NMR (CDCl3) δ: 
1.56—2.05 (2H, m, disappeared on addition of D2O), 2.41 (1H, dd, J=11.5, 5.1 Hz), 2.49 (1H, td, J=11.5, 
6.6 Hz), 2.81 (1H, td, J=11.5, 5.1 Hz), 3.21 (1H, dd, J=11.5, 6.6 Hz), 3.77 (3H, s), 5.12 (1H, s), 6.63 (1H, 
d, J=7.6 Hz), 6.70 (1H, t, J=7.6 Hz), 6.82 (2H, dm, J=8.7 Hz), 6.93 (1H, dd, J=7.6, 0.9 Hz), 7.04 (1H, td, 
 J=7.6, 0.9 Hz), 7.25 (2H, dm, J=8.7 Hz). High-resolution MS m/z: Calcd for C17H18N2O: 266.1419. 
Found: 266.1412.   
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-3a-(4-hydoroxyphenyl)- (14) and -3a-(2-hydoroxyphenyl)- 
1-trifluoroacetylpyrrolo[2,3-b]indole (15) from 2 — A solution of MsCl (226.7 mg, 1.99 mmol) in 
anhydrous CHCl3 (1.0 mL) was added to a solution of 2 (107.2 mg, 0.39 mmol ) and phenol (370.5 mg, 
3.94 mmol) in anhydrous CHCl3 (3.0 mL) and Et3N (0.27 mL, 1.94 mmol) at 0 °C and the mixture was 
stirred at 0 °C for 1 h. After addition of H2O under ice cooling, the whole was extracted with 
CHCl3–MeOH (95:5, v/v). The extract was washed with brine, dried over Na2SO4, and evaporated under 
reduced pressure to leave an oil, which was column-chromatographed on SiO2 successively with 
CHCl3–hexane (2:1, v/v) and EtOAc–hexane (1:5, v/v) to give 11a (8.0 mg, 8%), 1 (7.6 mg, 8%), 15 (7.4 
mg, 5%), 14 (4.0mg, 3%), and 6 (5.1 mg, 4%) in the order of elution. 14: colorless oil. IR (film): 1678, 
1203, 1188, 1151, 754 cm-1. 1H-NMR (CDCl3) δ: 2.66—2.79 (2H, m), 3.32—3.41 (1H, m), 4.00—4.09 
(1H, m), 4.91 (1H, br s, disappeared on addition of D2O), 5.21 (1H, br s, disappeared on addition of D2O), 
5.64 (1H, s), 6.68 (1H, d, J=7.6 Hz), 6.76 (2H, m), 6.79 (1H, td, J=7.6, 0.6 Hz), 7.05 (1H, d, J=7.6 Hz), 
7.12 (1H, td, J=7.6, 1.1 Hz), 7.26 (2H, m). High-resolution MS m/z: Calcd for C18H15F3N2O2: 348.1086. 
Found: 348.1086. 15: colorless oil. IR (film): 1709, 1211, 1184, 1165, 750 cm-1. 1H-NMR (CDCl3) δ: 
2.34—2.43 (1H, m), 2.43—2.52 (1H, m), 3.22—3.32 (1H, m), 3.35—3.45 (1H, m), 5.04 (1H, br s), 6.21 
(1H, d, J=1.7 Hz, collapsed to s on addition of D2O), 6.31 (1H, br s), 6.70 (1H, d, J=7.6 Hz), 6.78 (1H, d, 
J=7.6 Hz), 6.81 (1H, td, J=7.6, 0.9 Hz), 6.91 (1H, td, J=7.6, 0.9 Hz), 7.09 (1H, td, J=7.6, 1.3 Hz), 7.12 
(1H, td, J=7.6, 1.3 Hz), 7.19 (1H, d, J=7.6 Hz), 7.32 (1H, dd, J=7.6, 1.3 Hz). High-resolution MS m/z: 
Calcd for C18H15F3N2O2: 348.1085. Found: 348.1084.  
12 from 14 — Excess CH2N2 in Et2O was added to a solution of 14 (3.7 mg, 0.01 mmol) in MeOH (0.5 
mL) and the mixture was stirred at rt for 30 min. The solvent was evaporated under reduced pressure to 
leave an oil, which was column-chromatographed on SiO2 with CHCl3–hexane (2:1, v/v) to give 12 (2.8 
mg, 73%).  
(3a,8a-cis)-1,2,3,3a,8,8a-Hexahydro-3a-(pyrrol-2-yl)-1-trifluoroacetylpyrrolo[2,3-b]indole (16) from 
2 — A solution of MsCl (60.1 mg, 0.53 mmol) in anhydrous CHCl3 (1.0 mL) was added to a solution of 2 
(106.2 mg, 0.39 mmol ) and pyrrole (263.6 mg, 3.93 mmol) in anhydrous CHCl3 (3.0 mL) and Et3N (0.4 
mL, 2.87 mmol) at 0 °C and the mixture was stirred at 0 °C for 1 h. After addition of H2O under ice 
cooling, the whole was extracted with CHCl3–MeOH (95:5, v/v). The extract was washed with brine, 
dried over Na2SO4, and evaporated under reduced pressure to leave an oil, which was 
column-chromatographed on SiO2 with EtOAc–hexane (1:5, v/v) and CHCl3–MeOH (99:1, v/v) to give 3 
(5.6mg, 6%), 16 (36.5mg, 29%), 11a (8.3 mg, 8%), and 1 (6.9mg, 7%) in the order of elution. 16: 
 colorless oil. IR (film): 1684, 1483, 1468, 1205, 1188, 1747, 754 cm-1. 1H-NMR (DMSO-d6) δ: 
2.34—2.70 (2H, m), 3.04—3.13 (1/5H, m), 3.16—3.27 (4/5H, m), 3.90—3.98 (4/5H, m), 3.99—4.06 
(1/5H, m), 5.61 (4/5H, s), 5.62—5.67 (1H, m), 5.67—5.71 (1/5H, m), 5.83—5.89 (1H, m), 6.62 (4/5H, d, 
J=7.6 Hz), 6.65 (1/5H, d, J=7.6 Hz), 6.67—6.76 (3H, m), 7.04 (4/5H, td, J=7.6, 1.2 Hz), 7.07 (1/5H, td, 
J=7.6, 1.2 Hz), 7.41 (1/5H, d, J=7.6 Hz), 7.22 (4/5H, d, J=7.6 Hz), 10.81 (1H, br s). High-resolution MS 
m/z: Calcd for C16H14F3N3O: 321.1089. Found: 321.1083. 
(3a,8a-cis)-8-Acetyl-1,2,3,3a,8,8a-hexahydro-3a-(pyrrol-2-yl)-1-trifluoroacetylpyrrolo[2,3-b]indole 
(18) from 16 — Ac2O (2.0 mL) was added to a solution of 16 (36.2mg, 0.11 mmol) in pyridine (2.0 mL) 
and the mixture was stirred at 65 °C for 10 h. The solvent was evaporated under reduced pressure to leave 
an oil, which was column-chromatographed on SiO2 with EtOAc–hexane (1:4, v/v) to give 18 (33.9 mg, 
83%). 18: mp 218.0—220.0 °C (colorless powder, recrystallized from EtOAc–hexane). IR (KBr): 3263, 
1705, 1662, 1151, 760 cm-1. 1H-NMR (CDCl3) δ: 2.47 (3H, s), 2.62 (1H, dd, J=12.7, 5.3 Hz), 2.78 (1H, td, 
J=12.7, 7.5 Hz), 3.22 (1H, td, J=12.7, 5.3 Hz), 4.02 (1H, m), 6.02 (1H, s), 6.16—6.22 (2H, m), 
6.74—6.78 (1H, m), 7.19—7.28 (2H, m), 7.39 (1H, ddd, J=8.1, 7.1, 1.8 Hz), 7.79 (1H, br s, disappeared 
on addition of D2O), 8.06 (1H, d, J=8.1 Hz). Anal. Calcd for C18H16F3N3O2: C, 59.50; H, 4.44; N, 11.57. 
Found: C, 59.61; H, 4.43; N, 11.56.  
(3a,8a-cis)-8-Acetyl-1,2,3,3a,8,8a-hexahydro-3a-(indol-3-yl)-1-trifluoroacetylpyrrolo[2,3-b]indole 
(19) from 5 — Ac2O (3.0 mL) was added to a solution of 5 (22.0 mg, 0.06 mmol) in pyridine (3.0 mL) 
and the mixture was stirred at 62 °C for 9.5 h. The solvent was evaporated under reduced pressure to 
leave an oil, which was column-chromatographed on SiO2 with EtOAc–hexane (1:2, v/v) to give 19 (12.5 
mg, 51%). 19: mp 219.0—220.5°C (colorless prisms, recrystallized from CHCl3). IR (KBr): 3360, 1679, 
1479, 1462, 1388, 1206, 1142, 740 cm-1. 1H-NMR (CDCl3) δ: 2.41 (3H, s), 2.58 (1H, dd, J=12.5, 5.1 Hz), 
3.04 (1H, td, J=12.5, 7.3 Hz), 3.30 (1H, td, J=12.5, 5.1 Hz), 4.09 (1H, m), 6.43 (1H, br s), 6.71 (1H, d, 
J=2.7 Hz), 7.13 (1H, t, J=8.1 Hz), 7.22 (1H, t, J=8.1 Hz), 7.23 (1H, t, J=8.1 Hz), 7.30—7.34 (2H, m), 
7.38 (1H, t, J=8.1 Hz), 7.39 (1H, d, J=8.1 Hz), 8.10 (1H, br s), 8.16 (1H, br s). High-resolution MS m/z: 
Calcd for C22H18F3N3O2: 413.1351. Found: 413.1353. Anal. Calcd for C22H18F3N3O2·1/4H2O: C, 63.23; 
H, 4.34; N, 10.05. Found: C, 63.00; H, 4.37; N, 9.81.   
(3a,8a-cis)-8-Acetyl-1,2,3,3a,8,8a-hexahydro-3a-(indol-2-yl)-1-trifluoroacetylpyrrolo[2,3-b]indole 
(20) from 4 — Ac2O (2.0 mL) was added to a solution of 4 (20.5 mg, 0.03 mmol) in pyridine (2.0 mL) 
and the mixture was stirred at 63 °C for 10 h. The solvent was evaporated under reduced pressure to leave 
an oil, which was column-chromatographed on SiO2 with EtOAc–hexane (1:5, v/v) to give 20 (22.1 mg, 
97 %). 20: mp 147.0—150.0 °C (colorless fine needles, recrystallized from CHCl3–hexane). IR (KBr): 
1709, 1662, 1479, 1394, 1147, 1142, 1124, 750 cm-1. 1H-NMR (CDCl3) δ: 2.46 (3H, s), 2.71 (1H, dd, 
 J=12.5, 5.1 Hz), 2.91 (1H, td, J=12.5, 7.2 Hz), 3.27 (1H, td, J=12.5, 5.1 Hz), 4.09 (1H, m), 6.19 (1H, s), 
6.51 (1H, dd, J=2.2, 0.7 Hz), 7.11 (1H, ddd, J=8.1, 7.0, 1.1 Hz), 7.17 (1H, ddd, J=8.1, 7.0, 1.1 Hz), 
7.21—7.29 (3H, m), 7.38—7.45 (1H, m), 7.58 (1H, dd, J=8.1, 1.1 Hz), 7.94 (1H, br s), 8.11 (1H, d, 
J=8.1Hz). High-resolution MS m/z: Calcd for C22H18F3N3O2: 413.1351. Found: 413.1351. 
1-Acetyl-6-mesyloxy-Nb-trifluoroacetyltryptamine (21) from 6 — Reported in our previous paper.9 
(3a,8a-cis)-3a-Acetoxy- (22) and (3a,8a-cis)-3a-acetoxy-8-acetyl-1,2,3,3a,8,8a-hexahydro-1-trifluo- 
roacetylpyrrolo[2,3-b]indole (23) from 9 — Ac2O (5.0 mL) was added to a solution of 9 (40.9 mg, 0.15 
mmol) in pyridine (5.0 mL) and the mixture was stirred at rt for 18 h. The solvent was evaporated under 
reduced pressure to leave an oil, which was column-chromatographed on SiO2 successively with 
CHCl3–hexane (1:2, v/v/) and CHCl3 to give 22 (33.5 mg, 71%) and 23 (9.0 mg, 17%) in the order of 
elution. 22: colorless oil. IR (film): 1741, 1693, 1240, 1205, 1146 cm-1. 1H-NMR (CDCl3) δ: 2.04 (12/5H, 
s), 2.05 (3/5H, s), 2.51—2.60 (1/5H, m), 2.68 (4/5H, ddd, J=12.9, 11.6, 8.3 Hz), 2.77 (1/5H, dd, J=12.4, 
6.0 Hz), 3.04 (4/5H, ddd, J=12.9, 6.2, 1.5 Hz), 3.17 (1/5H, td, J=12.4, 6.0 Hz), 3.41 (4/5H, td, J=11.6, 6.2 
Hz), 4.02 (4/5H, m), 4.22 (1/5H, dd, J=12.4, 8.3 Hz), 4.81 (1/5H, br d, J=4.0 Hz disappeared on addition 
of D2O), 5.18 (4/5H, br s, disappeared on addition of D2O), 5.81 (4/5H, d, J=2.0 Hz, collapsed to s on 
addition of D2O), 5.95—5.98 (1/5H, m), 6.67 (4/5H, d, J=7.6 Hz), 6.69 (1/5H, d, J=7.6 Hz), 6.82 (4/5H, 
td, J=7.6, 1.1 Hz), 6.86 (1/5H, td, J=7.6, 1.1 Hz), 7.22 (4/5H, td, J=7.6, 1.3 Hz), 7.23 (1/5H, td, J=7.6, 1.3 
Hz), 7.41 (1/5H, d, J=7.6 Hz), 7.51(4/5H, d, J=7.6 Hz). High-resolution MS m/z: Calcd for 
C14H13F3N2O3: 314.0878. Found: 314.0881. 23: mp 117.5—118.0 °C (colorless prisms, recrystallized 
from EtOAc–hexane). IR (KBr): 1745, 1701, 1685, 1373, 1242, 1133, 758 cm-1. 1H-NMR (CDCl3) δ: 
2.05 (3H, s), 2.59 (3H, s), 2.59 (1H, td, J=12.7, 7.8 Hz), 2.90 (1H, dd, J=12.7, 5.1 Hz), 3.13 (1H, ddd, 
J=12.7, 11.7, 5.1 Hz), 4.00 (1H, m), 6.40 (1H, br s), 7.19 (1H, td, J=7.4, 1.0 Hz), 7.42 (1H, ddd, J=8.1, 
7.4, 1.2 Hz), 7.53 (1H, dd, J=8.1, 1.0 Hz), 8.04 (1H, br d, J=7.4 Hz). High-resolution MS m/z: Calcd for 
C16H15F3N2O4: 356.0984. Found: 356.0994. Anal. Calcd for C16H15F3N2O4: C, 53.94; H, 4.24; N, 7.86. 
Found: C, 53.98; H, 4.18; N, 7.62. 
23 from 22 — Ac2O (5.0 mL) was added to a solution of 22 (33.5 mg, 0.10 mmol) in pyridine (5.0 mL) 
and the mixture was stirred at 55 °C for 32 h. The solvent was evaporated under reduced pressure to leave 
an oil, which was column-chromatographed on SiO2 with CHCl3–hexane (1:1, v/v/) to give unreacted 22 
(8.7 mg, 26%) and 23 (23.7 mg, 62%) in the order of elution. 
(3a,8a-cis)-3a-Acetoxy-8-acety-1,2,3,3a,8,8a-hexahydro- (24) and (3a,8a-cis)-8-acety-1,2,3,3a,8,8a- 
hexahydro-3a-hydroxypyrrolo[2,3-b]indole (25) from 23 — Sat. aq. NaHCO3 (4.0 mL, 4.2 mmol) was 
added to a solution of 23 (39.7 mg, 0.11 mmol) in MeOH (5.0 mL) and the mixture was stirred at rt for 20 
min. The solvent was evaporated under reduced pressure to leave a solid, which was 
column-chromatographed on SiO2 successively with CHCl3–MeOH–AcOH (46:1:0.1, v/v) and 
 CHCl3–MeOH–AcOH (46:10:1, v/v) to give 24 (23.3 mg, 80%) and 25 (4.5 mg, 19%) in the order of 
elution. 24: mp 125.0—126.0 °C (very pale yellow prisms, recrystallized from EtOAc–hexane). IR (KBr): 
3315, 1739, 1649, 1483, 1408, 1238, 1047 cm-1. 1H-NMR (DMSO-d6) δ: 1.99 (3H, s), 2.24 (3H, s), 
2.29—2.54 (3H, m), 2.97—3.09 (1H, m), 3.37 (1H, br s, disappeared on addition of D2O), 5.63 (1H, br d, 
J=2.2 Hz, collapsed to s on addition of D2O ), 7.06 (1H, td, J=7.6, 1.1 Hz), 7.28 (1H, ddd, J=8.3, 7.6, 1.1 
Hz), 7.45 (1H, dd, J=7.6, 1.1 Hz), 8.01 (1H, d, J=8.3 Hz). Anal. Calcd for C14H16N2O3: C, 64.60; H, 6.20; 
N, 10.76. Found: C, 64.50; H, 6.26; N, 10.63. 25: mp 196.0—197.0 °C (colorless prisms, recrystallized 
from MeOH–EtOAc). IR (KBr): 3342, 3294, 1641, 1483, 1406, 762 cm-1. 1H-NMR (CD3OD) δ: 
2.28—2.34 (2H, m), 2.31 (3H, s), 2.53—2.63 (1H, m), 3.06—3.14 (1H, m), 5.25 (1H, s), 7.16 (1H, td, 
J=7.4, 1.0 Hz), 7.30 (1H, ddd, J=8.3, 7.4, 1.0 Hz), 7.44 (1H, d, J=7.4 Hz), 8.12 (1H, d, J=8.3 Hz). Anal. 
Calcd for C12H14N2O2: C, 66.03 H, 6.47; N, 12.84. Found: C, 66.01; H, 6.48; N, 12.82. 
25 from 23 — Sat. aq. NaHCO3 (4.0 mL, 4.2 mmol) was added to a solution of 23 (40.2 mg, 0.11 mmol) 
in MeOH (5.0 mL) and the mixture was refluxed for 30 min with stirring. The solvent was evaporated 
under reduced pressure to leave a solid, which was column-chromatographed on SiO2 with CHCl3– 
MeOH–AcOH (46:5:0.5, v/v) to give 25 (24.2 mg, 98%).  
(3a,8a-cis)-3a-Acetoxy-1,8-diacetyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (26) from 24 — 
Ac2O (2.0 mL) was added to a solution of 24 (18.6mg, 0.07 mmol) in pyridine (4.0 mL) and the mixture 
was stirred at rt for 1 h. The solvent was evaporated under reduced pressure to leave an oil, which was 
column-chromatographed on SiO2 with CHCl3–MeOH (98:2, v/v/) to give 26 (20.8 mg, 96%). 
26 from 25 — Ac2O (3.0 mL) was added to a solution of 25 (29.7 mg, 0.14 mmol) in pyridine (6.0 mL) 
and the mixture was stirred at rt for 16 h. The solvent was evaporated under reduced pressure to leave an 
oil, which was column-chromatographed on SiO2 with CHCl3–MeOH (98:2, v/v/) to give 26 (40.9 mg, 
99%). 
26 from Nb-acetyl-1-hydroxytryptamine (27) — NaOAc (23.9 mg, 0.29 mmol) was added to a solution 
of 27 (31.3 mg, 0.14 mmol) in Ac2O (2.0 mL) and the mixture was stirred at 118–122 °C for 4.5 h. After 
addition of H2O under ice cooling, the whole was extracted with CHCl3–MeOH (95:5, v/v). The extract 
was washed with brine, dried over Na2SO4, and evaporated under reduced pressure to leave an oil, which 
was column-chromatographed on SiO2 with CHCl3–MeOH (98:2, v/v) to give 26 (20.5 mg, 47%). 26: 
mp190.0—191.0 °C (colorless prisms, recrystallized from CHCl3–hexane ). IR (KBr): 3535, 2875, 1742, 
1623, 1603, 1477, 1404, 1239, 1043, 904, 789, 769 cm-1. 1H-NMR (DMSO-d6, 60 °C) δ: 1.99, (3H, s), 
2.04 (3H, br s), 2,43 (3H, s), 2.45—2.58 (1H, m), 2.64 (1H, br dd, J=11.5, 4.4 Hz), 2.82 (1H, m), 3.84 
(1H, m), 6.34 (1H, br s), 7.16 (1H, t, J=7.6 Hz), 7.35 (1H, t, J=7.6 Hz), 7.52 (1H, d, J=7.6 Hz), 7.86 (1H, 









































6.00; N, 9.17. 
(3a,8a-cis)-1-Acetyl-1,2,3,3a,8,8a-hexahydro-3a-hydroxypyrrolo[2,3-b]indole (29) from 8b-(2- 
acetylaminoethyl)-2,2-dimethyl-4H-1,3-dioxolo[4,5-b]indole (28) — K2CO3 (16.6 mg, 0.12 mmol) was 
added to a solution of 28 (6.5 mg, 0.02 mmol) in MeOH (1.0 mL) and the mixture was stirred at rt for 45 
min. After addition of H2O, the whole was extracted with CHCl3–MeOH (95:5, v/v). The extract was 
washed with brine, dried over Na2SO4, and evaporated under reduced pressure to leave an oil, which was 
column-chromatographed on SiO2 with CHCl3–MeOH (97:3, v/v) to give 29 (4.1 mg, 80%). 29: colorless 
oil. IR (film): 3320, 1613, 1470, 1449, 1423, 1060, 752 cm-1. 1H-NMR (CDCl3) δ: 2.03 (3H, s), 2.45 (1H, 
s, disappeared on addition of D2O), 2.41—2.57 (2H, m), 3.25—3.33 (1H, m), 3.67—3.75 (1H, m), 5.27 
(1H, br s, disappeared on addition of D2O), 5.33 (1H, s), 6.63 (1H, d, J=7.6, 1.0 Hz), 6.81 (1H, td, J=7.6, 
1.0 Hz), 7.19 (1H, td, J=7.6, 1.2 Hz), 7.31 (1H, d, J=7.6, 1.2 Hz). High-resolution MS m/z: Calcd for 
C12H14N2O2: 218.1056. Found: 218.1056. 
26 from 29 — Ac2O (0.5 mL) was added to a solution of 29 (6.5 mg, 0.03 mmol) in pyridine (1.0 mL) at 
0 °C and the mixture was stirred at rt for 8 h. The solvent was evaporated under reduced pressure to leave 
an oil, which was column-chromatographed on SiO2 with EtOAc to give 26 (7.2 mg, 80%).  
X-Ray Crystallographic Analysis of 4 — A single crystal (0.20x0.20x0.20 mm) of 4 was obtained by 
recrystallization from CHCl3. All measurements was made on a Rigaku AFC5R diffractometer with 
graphite monochromated Cu-Kα radiation (λ=1.54178 Å). Crystal data: C20H16F3N3O, M=454.52, 
monoclinic, space group P21/n (#14), a=8.8339 (5) Å, b=12.1938 (8) Å, c=15.7993 (9) Å, β=93.072 (5)°, 
V=1699.4 (2) Å3, Z=4, Dcalc=1.451 g/cm3, F(000)=768, and µ(CuKα)=9.40 cm–1. The structure was 
solved by direct methods using MITHRIL.14 The non-hydrogen atoms were refined anisotropically. The 
final cycle of full-matrix least-squares refinement was based on 1866 observed reflections (I>3.00σ (I), 
2θ <120.2°) and 308 variable parameters. The final refinement converged with R=0.046 and Rw=0.056. 
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 atom x y z B (eq) atom x y z B (eq)
F (1) 0.8894 (4) 0.3539 (2)  -0.0913 (1) 9.5 (2) C (16) 1.2211 (5)  -0.2951 (4) 0.3706 (3) 5.2 (2)
F (2) 0.9224 (3) 0.4006 (2) 0.0360 (1) 6.9 (1) C (17) 1.1484 (4)  -0.2638 (3) 0.2948 (2) 4.2 (2)
F (3) 0.7035 (3) 0.3547 (2)  -0.0115 (2) 8.4 (2) C (18) 1.0776 (3)  -0.1627 (3) 0.2925 (2) 3.2 (1)
O (1) 0.9367 (3) 0.1526 (2)  -0.0456 (1) 4.5 (1) C (19) 0.8815 (3) 0.2115 (3) 0.0073 (2) 3.5 (1)
N (1) 0.8435 (3) 0.1775 (2) 0.0829 (1) 3.2 (1) C (20) 0.8490 (5) 0.3308 (3)  -0.0157 (2) 4.9 (2)
N (2) 0.7651 (3)  -0.0136 (2) 0.0658 (2) 3.7 (1) H (1) 0.659 (4) 0.235 (3) 0.141 (2) 4.85 (2)
N (3) 0.9933 (3)  -0.1117 (2) 0.2279 (2) 3.3 (1) H (2) 0.802 (4) 0.313 (3) 0.143 (2) 4.82 (2)
C (1) 0.7749 (5) 0.2386 (3) 0.1515 (2) 4.0 (2) H (3) 0.775 (4) 0.191 (3) 0.278 (2) 4.65 (2)
C (2) 0.8370 (4) 0.1792 (3) 0.2289 (2) 3.8 (2) H (4) 0.943 (4) 0.202 (3) 0.246 (2) 4.46 (2)
C (3) 0.8378 (3) 0.0585 (2) 0.2022 (2) 3.0 (1) H (5) 0.611 (3) 0.023 (3) 0.318 (2) 4.11 (2)
C (4) 0.6797 (3) 0.0077 (2) 0.1983 (2) 3.0 (1) H (6) 0.377 (4)  -0.067 (3) 0.288 (2) 5.31 (2)
C (5) 0.5790 (4)  -0.0033 (3) 0.2614 (2) 3.8 (2) H (7) 0.319 (4)  -0.138 (3) 0.150 (2) 6.04 (2)
C (6) 0.4432 (4)  -0.0568 (3) 0.2429 (3) 4.6 (2) H (8) 0.489 (4)  -0.117 (3) 0.044 (2) 4.73 (2)
C (7) 0.4104 (4)  -0.0976 (3) 0.1633 (3) 5.1 (2) H (9) 0.755 (4)  -0.019 (3) 0.021 (2) 4.46 (2)
C (8) 0.5101 (4)  -0.0868 (3) 0.0987 (3) 4.5 (2) H (10) 0.972 (3) 0.038 (2) 0.097 (2) 3.09 (2)
C (9) 0.6449 (3)  -0.0331 (2) 0.1181 (2) 3.3 (1) H (11) 0.985 (3)  -0.136 (2) 0.175 (2) 3.58 (2)
C (10) 0.8709 (3) 0.0615 (2) 0.1066 (2) 3.0 (1) H (12) 0.976 (3) 0.066 (3) 0.373 (2) 4.43 (2)
C (11) 0.9450 (3)  -0.0108 (3) 0.2557 (2) 3.2 (1) H (13) 1.156 (4)  -0.078 (3) 0.489 (2) 5.69 (2)
C (12) 0.9957 (4) 0.0028 (3) 0.3377 (2) 3.8 (2) H (14) 1.271 (4)  -0.249 (3) 0.494 (2) 6.35 (3)
C (13) 1.0796 (3)  -0.0923 (3) 0.3630 (2) 3.6 (1) H (15) 1.266 (4)  -0.362 (3) 0.373 (2) 5.70 (3)
C (14) 1.1544 (4)  -0.1271 (3) 0.4388 (2) 4.7 (2) H (16) 1.143 (3)  -0.310 (3) 0.246 (2) 4.57 (2)
C (15) 1.2235 (5)  -0.2281 (4) 0.4415 (3) 5.4 (2)

















REFERENCES AND NOTES 
1. a) This is Part 143 of a series entitled “The Chemistry of Indoles”; b) Part 142: T. Iwaki, Y. Fukui, M. 
Okigawa, F. Yamada, Y. Nagahama, S. Ogasawara, S. Tanaka, S. Funaki, and M. Somei, 
Heterocycles, 2016, 93, in press. COM-15-S(T)40 .   
2. Professor Emeritus of Kanazawa University. Present address: 56-7 Matsuhidai, Matsudo, Chiba 
270-2214, Japan. 
3. a) T. Kawasaki, M. Tabata, K. Nakagawa, K. Kobayashi, A. Kodama, T. Kobayashi, M. Hasegawa, 
K. Tanii, and M. Somei, Heterocycles, 2015, 90, 1038, and references cited therein; b) Recent 
application of 1-hydroxyindole to the synthesis of benzofuroindolines: T. Tomakinian, C. 
Kouklovsky, and G. Vincent, Synlett., 2015, 1269.  
4. a) F. Yamada, D. Shinmyo, M. Nakajou, and M. Somei, Heterocycles, 2012, 86, 435, and references 
cited therein. b) K. Yoshino, F. Yamada, and M. Somei, Heterocycles, 2008, 76, 989, and references 
cited therein. 
5. a) M. Somei, Yakugaku Zasshi, 2008, 128, 527, and references cited therein; b) M. Somei, Topics in   
Heterocyclic Chemistry, Vol. 6, ed. by S. Eguchi, Springer-Verlag, Berlin, 2006, pp. 77—111; c) M. 
Somei, Advances in Heterocyclic Chemistry, Vol. 82, ed. by A. R. Katritzky, Elsevier Science (USA), 
 2002, pp. 101—155; d) M. Somei, Heterocycles, 1999, 50, 1157; e) M. Somei, J. Synth. Org. Chem. 
Jpn, 1991, 49, 205. 
6. There is a possibility that the elimination of 1-hydroxy group and an attack by nucleophiles follow a 
concerted mechanism. 
7. F. Yamada, A. Goto, and M. Somei, Heterocycles, 2000, 53, 1255.  
8. M. Somei, N. Oshikiri, M. Hasegawa, and F. Yamada, Heterocycles, 1999, 51, 1237.  
9. M. Hasegawa, Y. Nagahama, K. Kobayashi, M. Hayashi, and M. Somei, Heterocycles, 2000, 52, 
483. 
10. H. Minato, M. Matsumoto, and T. Katayama, J. Chem. Soc., Perkin Trans. 1, 1973, 1819. 
11. D. Crich, E. Fredette, and W. J. Flosi, Heterocycles, 1998, 48, 545.  
12. M. Somei, F. Yamada, A. Goto, M. Hayashi, and M. Hasegawa, Heterocycles, 2000, 53, 2487. 
13. C. Takahashi, A. Numata, Y. Ito, E. Matsumura, H. Iwaki, and K. Kushida, J. Chem. Soc., Perkin 
Trans. 1, 1994, 1859. 
14. C. J. Gilmore, J. Appl. Cryst., 1984, 17, 42.  
 
 
 
